Sentences with phrase «pharmaceutical research as»

The BLS also cites higher rates of chronic diseases among all age groups and advances in pharmaceutical research as contributing factors.

Not exact matches

But, as part of Beijing's «Made in China 2025» industry plan, President Xi Jinping identified the pharmaceutical sector as one to push, with the focus on innovation and homegrown research and development.

The CRO industry is undergoing a wave of consolidation as pharmaceutical companies strive to cut costs, reduce clinical trial times and expand their research and development presence.

Her research focuses on innovation and strategy in high technology industries such as smartphones, video games, pharmaceuticals, biotechnology, electric vehicles, and renewable energies.

But as if to advertise its success and thumb an unwrinkled nose at the government, in early November Allergan announced plans to build a US$ 12 - billion research facility in New Jersey, a state with a big pharmaceutical sector hurt by the recession — and home to lots of rich housewives.

Citron Research's Andrew Left, who's gained notoriety for successful bets against companies such as Valeant Pharmaceuticals, on Monday posted a new bearish report on Shopify.

Many pharmaceutical companies continue to work on treatments for neurological diseases, as do many smaller biotech firms and academic medical research centers, and funding sources for these pursuits include private foundations as well as governments.

Maximizing support for the efforts of those such as Michael J. Fox Foundation for Parkinson's Research and academic medical research centers is key, especially now because other major pharmaceutical companies could follow Pfizer's dResearch and academic medical research centers is key, especially now because other major pharmaceutical companies could follow Pfizer's dresearch centers is key, especially now because other major pharmaceutical companies could follow Pfizer's decision.

Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California; Editor - in - Chief, Medscape Disclosure: Eric J. Topol, MD, has disclosed the following relevant financial relationships: Serve [d] as a director, officer, partner, employee, advisor, consultant, or trustee for: AltheaDX; Biological Dynamics; Cypher Genomics (Co-founder); Dexcom; Genapsys; Gilead Sciences, Inc.; Portola Pharmaceuticals; Quest Diagnostics; Sotera Wireless; Volcano Received research grant from: National Institutes of Health; Qualcomm FoResearch Institute, La Jolla, California; Editor - in - Chief, Medscape Disclosure: Eric J. Topol, MD, has disclosed the following relevant financial relationships: Serve [d] as a director, officer, partner, employee, advisor, consultant, or trustee for: AltheaDX; Biological Dynamics; Cypher Genomics (Co-founder); Dexcom; Genapsys; Gilead Sciences, Inc.; Portola Pharmaceuticals; Quest Diagnostics; Sotera Wireless; Volcano Received research grant from: National Institutes of Health; Qualcomm Foresearch grant from: National Institutes of Health; Qualcomm Foundation

This unique event will bring together researchers and clinicians from major cancer research centers and institutes as well as experts from the biotech and pharmaceutical industries.

Prior to that, Dr. Armstrong served as Senior Vice President at Merck Serono, Executive Vice President Product Development at Bayer AG, and Senior Vice President Medical Research at Zeneca Pharmaceuticals (now AstraZeneca).

As Poppe put it: «Valeant and the chief executive [Michael Pearson] had a good insight, which is that the U.S. pharmaceutical industry was spending a lot of money on [research and development] and not getting a great return on original research and development ideas.»

METTLER TOLEDO is also one of the top three providers of various related measurement technologies as well as a leading vendor of systems for automated pharmaceutical research and the development of active ingredients.

But her mysteries also delve into moregeneral topics such as community development, pharmaceutical research, theenvironment and family dynamics.

With neurological disorders affecting approximately one - third of the U.S. population, and pharmaceutical firms largely abandoning their R&D efforts in neuroscience, the work of academic research institutions such as CSHL is crucial in the effort to drive innovation and discovery in this field.»

As neurological disorders affect approximately one - third of the U.S. population, and pharmaceutical firms are largely abandoning their research and development efforts in neuroscience, the work of academic research institutions is crucial in the effort to drive innovation and discovery in this field.

Genius mathematicians probably also make fairly amazing pharmaceutical researchers, entrepreneurs, or engineers, so conceivably there could be more advances in the applied sciences and wealth creation in a world without as much math research.

The Buffalo Billion includes more than a dozen other regional projects, a potpourri of state - backed ventures such as an information technology hub, a pharmaceutical research center, a pediatric hospital, a visual effects center, various residential redevelopments and even a candy store renovation.

Funding is in the form of 11 million pounds from the Wellcome Trust, a London - based foundation that supports research on animal and human health, and contributions to individual institutions from companies such as GlaxoSmithKline, Pfizer, Roche, AstraZeneca, Sanofi - Aventis, Sirtris Pharmaceuticals, and PTC Therapeutics.

Most of the students enter the program as working professionals: approximately two - thirds come from the pharmaceutical, biologics, and medical device industries, while the remaining third are employed in contract research organizations and other scientific organizations.

Across the broad range of life science research under way in biotechnology and pharmaceuticals, many companies need scientists with traditional skills, such as pharmacology or biology.

So, I took a job as a research scientist in the analytical lab of a smaller chemistry - driven, discovery - based pharmaceutical company located in Vancouver, B.C. With fewer than 100 employees and no products on the market, it couldn't have been further from the formal corporate work environment I was accustomed to at a multinational company.

In a report, the commission argues that «[g] lobal governments should unite to offer multibillion - dollar incentives for drug developers, and pharmaceutical companies should pool their billions in support of early - stage research,» as Kelly Servick wrote Thursday at ScienceInsider.

After leaving research behind, I became a science editor for a firm that produces training materials for pharmaceutical sales representatives, a job that prepared me for my current role as MiSciNet editor.

We have seen a dramatic increase in automation and HTS needs in different fields of the chemical and pharmaceutical industries, such as catalysis research, synthesis, synthesis optimization, product control, and screening of microorganisms in recent years.

A possible alternative is to do research in industry but, as in many other developed countries, big companies in France have been shedding staff in recent years, in the pharmaceutical sector in particular, Trautmann says.

It consolidates five existing SFI research centers but brings onboard more than 40 different industry partners, including Abbott pharmaceuticals, the consulting firm Accenture, sportswear company Adidas, large multinational companies such as Intel and Microsoft, and media companies such as The Irish Times and Storyful.

«The perception of Wyeth as a strong science - driven pharmaceutical company is gaining ground and is a genuine transformation,» says Frank Walsh, vice president and head of discovery research.

High in the Cederberg Mountains of South Africa grows a bristly shrub that embodies the tug - of - war taking place between industrialized and developing nations over the value of genetic resources — the genes found in plant, animal or microbial cells used for research as well as in commercial products, such as enhanced seeds and naturally derived cosmetics and pharmaceuticals.

In addition to a socially responsible mission, other advantages of working in the biotechnology and pharmaceutical industry, as identified by survey takers, were: engaging work and being part of cutting - edge research and development; innovative, creative, and fast - paced work; and stability in difficult economic times, including generous salaries, benefits, and job security.

As such, opportunities for veterinary medical scientists run the gamut from biomedical and pharmaceutical research to public health and academia.

Besides helping scientists better gauge how precipitation ultimately soaks into sandy soils, the research could help them better understand industrial processes, such as pharmaceutical manufacture, in which liquids are sprayed onto dry powdered materials — possibly improving quality control and consistency in the final products.

«With the headcount constraints in today's economic climate, industry needs to hire leaders as well as technically excellent scientists,» says Scott Reines, newly retired vice president of pharmaceutical research and development at Johnson & Johnson, a pharmaceutical company based in New Brunswick, New Jersey.

In some cases these research opportunities arose from a joint venture between BPRU and a pharmaceutical company in the interest of furthering research, such as testing the abuse liability of a novel compound.

«A greater impact will be the tug this exerts on the pharmaceutical companies as they weigh up where to make their clinical research investments,» he argued.

Scientists have to be able to hit the ground running, as innovation in the pharmaceutical and biotechnology industries is a long and costly process, involving several stages of basic, applied, and clinical research, and often taking up to 15 years to complete.

«I was attracted to the applied nature of his research on cationic peptides as pharmaceutical agents, so I contacted Bob through e-mail and told him [of] my interest in nuclear magnetic resonance and his research.»

So, according to plan, I spent 10 years in research in the pharmaceutical industry (first with Wellcome and then Glaxo Wellcome), but as my career progressed I found myself becoming more and more interested in the strategic challenges facing the industry.

Graduating students might find employment in, for example, academia, national research laboratories, pharmaceuticals, industrial drug design, manufacturing and automotive, medical / health professions such as bioinformatics.

Now, Wyss Institute researchers led by Church have developed a new suite of such sensors, reported in Nucleic Acids Research journal, that not only increase the number of cellular «switches and levers» that scientists can use for complex genetic re-programming, but also respond to valuable products such as renewable plastics or costly pharmaceuticals and give microbes a voice to report on their own efficiency in making these products.

The work applies a data analysis model for the growth and maturation of biomedical research to characterize the progress of research on the pharmaceutical chemistry of oligonucleotide therapeutics, as well as the molecular targets, for their actions.

It could prove extremely useful in other fields where chirality plays an important role, such as chemical and pharmaceutical research.

As such, it provides a means of moving organoids from basic research to actual pharmaceutical and clinical applications in the future.

Bristol - Myers Squibb won its citation «for extending and enhancing human life through innovative pharmaceutical research and development, and for redefining the science of clinical study through groundbreaking and extremely complex clinical trials that are now recognized as industry models.»

In addition to pharmaceutical and chemical companies, commercial operations based on science include producers of cosmetics, food, and medical devices, as well as clinical research and environmental organizations.

Patrick Vallance, president of research and development at the pharmaceutical giant GlaxoSmithKline, has been appointed as chief scientific adviser, the UK government announced on 8 November.

Because my research interests had always been clinically oriented, I was keen to explore the possibility of working as a clinical research associate (CRA) for the pharmaceutical industry.

In 2015, Forbes reported that Yancopoulos became the first pharmaceutical research chief to become a billionaire, as a result of his work at Regeneron, which includes inventing four approved drugs and designing the technology to assist in making more.

It is generally thought that these compounds have reached the aquatic environment for as long as they have been commercially used, but only during the last decade or so has environmental research been widely conducted and concerns over the effects of pharmaceuticals in water bodies been raised.

But increasingly, he says, the pharmaceutical industry is farming out its clinical trials to for - profit entities, known as contract research organizations.